Correction: Low-Protein Diet Boosts Antitumor Immune Response in Pancreatic Cancer via Microbiota-Derived UDP-Galactose

By
Yueying Chen
Fulin Nian
Shengdi Wu
Tianli Yuan
Yifan Ma
Junyang Cao
Yuxiao Zhang
Wenfeng Liu
Wenqing Tang
Danying Zhang
Zi Li
Wei Lu
Fengwanni Wang
Xiulong Xia
Zhanju Liu
Si Zhang
Xizhong Shen
Xiaoming Hu
Ling Dong
August 25, 2026

Nature Cancer

Overview

This correction clarifies the legends for figures in the original article, specifying the effects of a low-protein diet on pancreatic ductal adenocarcinoma (PDAC) and its immune response. The revised titles detail the activation of anti-tumor immune responses, the increase in tumor-associated macrophages, and the role of tumor microenvironment remodeling.

Background

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis and limited treatment options. Understanding the immune response in PDAC is crucial for developing effective therapies, particularly as immune checkpoint inhibitors have shown limited success in this malignancy.

Data Highlights

No numerical data or trial results are presented in the correction.

Key Findings

The correction specifies the activation of anti-tumor immune responses in PDAC with a low-protein diet.
It highlights the increase in tumor-associated macrophages in the context of PDAC.
The revised legends indicate the suppression of PDAC size through tumor microenvironment remodeling.

Clinical Implications

The clarification of the figures in this correction emphasizes the importance of dietary factors in the immune response to PDAC.

Conclusion

This correction provides important clarifications regarding the effects of a low-protein diet on the immune response in PDAC.

Correction: Low-Protein Diet Boosts Antitumor Immune Response in Pancreatic Cancer via Microbiota-Derived UDP-Galactose